General Information of the Compound
| Compound ID |
CP0049822
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[3-(1H-imidazol-5-yl)propyl]piperidine
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-[3-(1H-IMIDAZOL-4-YL)-PROPYL]-PIPERIDINE
4-[3-(1h-imidazol-4-yl)propyl]piperidine
768358-61-8
AKOS006290761
BDBM50409817
CHEBI:93084
CHEMBL78498
KB-333611
NCGC00167742-01
SCHEMBL15139142
VUF 5681
VUF-5681
ZINC13530263
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H19N3
|
||||||||||||||||||
| Molecular Weight |
193.294
|
||||||||||||||||||
| Canonical SMILES |
C(CC1CCNCC1)Cc1cnc[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H19N3/c1(3-11-8-13-9-14-11)2-10-4-6-12-7-5-10/h8-10,12H,1-7H2,(H,13,14)
Show/Hide
|
||||||||||||||||||
| InChIKey |
YPGRNKJNOSUCLY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT01711, Histamine H4 receptor
Clinical Information about the Compound